For patients who have progressed on endocrine therapy, consistent monitoring of blood counts and biomarker testing informs ...

A new study from Cedars-Sinai Cancer has revealed that doctors often misjudge the stage of early pancreatic cancer, with ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

Uterine cancer incidence and mortality rates are projected to increase significantly through 2050, according to a study ...

One system often used to stage cancer is called the TNM staging system. The letters T, N and M stand for: T: What is the ...

or pending for prostate cancer. biomarkers. Several co-authors reported multiple relationships with industry. Agarwal reported research funding to his institution from Arnivas, Astellas, AstraZeneca, ...

Slightly higher levels of cardiac biomarkers may predict an increased risk for incident cancer, according to a study published online.

Indian American biomedical researcher has reported novel biomarkers for colorectal, bladder, prostate, stomach and pancreatic ...

The Phase II trial will compare progression-free survival in lung cancer patients treated according to their molecular subtypes.

Patients on baseline steroids had lower ORR, and markedly shorter PFS survival and OS compared with those not receiving ...

The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined the pros and cons of biomarker-based ...